Overview


According to FutureWise analysis the market for anticoagulation therapy devices is expected to register a CAGR of 9.02% from 2023-2031.

Anticoagulants are drugs that help to reduce the formation of blood clots. It involves the administration of drugs, commonly known as blood thinners, to stop or treat conditions, including deep vein thrombosis (DVT), pulmonary embolism, and atrial fibrillation. Monitoring the efficacy of anticoagulation therapy is required to ensure the dosage is appropriate and to prevent complications like bleeding or clotting. These medications can help stop life-threatening conditions like heart attacks, strokes, and pulmonary embolisms, all of which can happen because of blood clots. Anticoagulation or clot prevention can be directed at different sites of the coagulation pathway, with overlaps at multiple points. Direct thrombin inhibitors and direct factor 10a inhibitors can inhibit the formation of a fibrin clot. Other mechanisms through which anticoagulation can be achieved include inhibiting vitamin K-dependent factors by preventing their synthesis in the liver or modifying their calcium-binding properties.

In recent years, there have been substantial advancements in anticoagulation therapy, especially in developing devices and technologies that facilitate accurate and convenient intervention. These innovations have helped healthcare experts in clinical settings and patients at home to monitor anticoagulation levels more effectively. Anticoagulation therapy devices include a range of fundamental tools, such as in-office testing devices, analyzers, reagents, kits, and convenient home testing devices. They offer healthcare professionals more precise tools for dosage adjustments, lowering the risks of over- or under-anticoagulation. Also, home testing devices encourage patients to participate more actively in their health, potentially leading to better compliance and enhanced overall quality of life.

FutureWise Market Research has published a report that provides an insightful analysis anticoagulation therapy devices market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anticoagulation therapy devices market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Roche
  • Abbott
  • Siemens
  • Alere
  • CoaguSense

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of cardiovascular diseases like arrhythmia, blood vessel thromboembolism, and stroke is expected to be a drive the growth of the anticoagulation therapy devices market. As these conditions become increasingly dominant in global populations, the need for effective anticoagulation therapy prompts the demand for advanced medical devices tailored to address these conditions. This increase in demand is poised to boost innovation and technological advancements in the field, further fueling market growth. Additionally, the shift towards personalized medicine may fuel the anticoagulation therapy devices market. This shift emphasizes treatments that are specifically calibrated to meet the requirements of each individual. As this trend achieves momentum, there's a growing need to design highly specialized anticoagulation devices developed to cater to individual patient needs. This enhances treatment efficiency and facilitates a more patient-centric practice to healthcare, further driving the demand for personalized medical solutions. However, the high cost of specific anticoagulation therapy devices poses a significant constraint, potentially impeding accessibility, especially in some developing regions with limited medical expenses. This economic barrier may restrict medical facilities and patients from accepting these crucial devices, leading to suboptimal therapy results for individuals who need them. Therefore, this hinders the growth of the anticoagulation therapy device market over the forecast period.

By Type

  • In-Office Testing Devices
  • Analyzers
  • Reagents and Kits
  • Home Testing Devices

By End User

  • Hospital
  • Clinic
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest revenue share in the market in 2022. This is attributed to factors such as the growing incidence of arrhythmia, blood vessel thromboembolism, and stroke, technological advancements, government funding for R&D activities, rising incidence of cardiovascular diseases, rise in R&D for the innovation of new oral anticoagulants, and an increasing focus on sustainability in the region is expected to boost the growth of anticoagulation therapy devices market over the forecast period. In addition, high healthcare expenditure, the growth of online pharmacies, increased use of anticoagulants as alternatives to antiplatelet drugs, and an increase in blood transfusions are also fueling the target growth during the projection period in the area.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anticoagulation Therapy Devices Market By Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anticoagulation Therapy Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anticoagulation Therapy Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anticoagulation Therapy Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anticoagulation Therapy Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In-Office Testing Devices
        2. Analyzers
        3. Reagents and Kits
        4. Home Testing Devices

  • 8.   Anticoagulation Therapy Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Clinic
        3. Others

  • 9.   North America Anticoagulation Therapy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Anticoagulation Therapy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Anticoagulation Therapy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Anticoagulation Therapy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Roche
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Siemens
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Alere
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. CoaguSense
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Shockwave Therapy Device Market

Read More

Sleep Diagnostics and Therapy Devices Market

Read More
Partner

Our Clients